Rockefeller University: Immunotherapy Drug Eliminates Aggressive Cancers in Clinical Trial
August 15, 2025
August 15, 2025
NEW YORK, Aug. 15 (TNSjou) -- Rockefeller University issued the following news:
* * *
Immunotherapy drug eliminates aggressive cancers in clinical trial
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise--and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact on patients in clinical trials and caused dangerously . . .
* * *
Immunotherapy drug eliminates aggressive cancers in clinical trial
Over the past 20 years, a class of cancer drugs called CD40 agonist antibodies have shown great promise--and induced great disappointment. While effective at activating the immune system to kill cancer cells in animal models, the drugs had limited impact on patients in clinical trials and caused dangerously . . .